Fig. 1From: Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational studyStudy designGal, Galcanezumab; Fre, Fremanezumab; Ere, Erenumab; CGRPmAb, anti-calcitonin gene-related peptide monoclonal antibodyBack to article page